Literature DB >> 3675018

Immunoglobulin A and C reactive protein levels in ankylosing spondylitis.

A Collado, R Sanmarti, M A Brancós, E Kanterewicz, T Gallart, J Rotés-Querol, A Cobos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3675018      PMCID： PMC1002244          DOI： 10.1136/ard.46.9.719

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  7 in total

1.  [Erythrocyte sedimentation rate and serum immunoglobulins in rheumatic pelvispondylitis].

Authors:  M Dougados; Y Gaudouen; M Blan; P Boumier; D Raichvarg; B Amor
Journal:  Rev Rhum Mal Osteoartic       Date:  1987-03

2.  IgA serum levels and disease activity in ankylosing spondylitis: a prospective study.

Authors:  M J Franssen; L B van de Putte; F W Gribnau
Journal:  Ann Rheum Dis       Date:  1985-11       Impact factor: 19.103

3.  Association of inflammation with raised serum IgA in ankylosing spondylitis.

Authors:  P Cowling; R Ebringer; A Ebringer
Journal:  Ann Rheum Dis       Date:  1980-12       Impact factor: 19.103

4.  Sequential studies in ankylosing spondylitis. Association of Klebsiella pneumoniae with active disease.

Authors:  R W Ebringer; D R Cawdell; P Cowling; A Ebringer
Journal:  Ann Rheum Dis       Date:  1978-04       Impact factor: 19.103

5.  HLA-B27 and the immune response to enterobacterial antigens in ankylosing spondylitis.

Authors:  A Trull; A Ebringer; G Panayi; R Ebringer; D C James
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

6.  IgA antibodies to Klebsiella pneumoniae in ankylosing spondylitis.

Authors:  A K Trull; R Ebringer; G S Panayi; D Colthorpe; D C James; A Ebringer
Journal:  Scand J Rheumatol       Date:  1983       Impact factor: 3.641

7.  C-reactive protein: a marker for disease activity in ankylosing spondylitis and Reiter's syndrome.

Authors:  D J Nashel; D L Petrone; C C Ulmer; A J Sliwinski
Journal:  J Rheumatol       Date:  1986-04       Impact factor: 4.666
  7 in total
  6 in total

1.  Increased levels of serum IgA as IgA1 monomers in ankylosing spondylitis.

Authors:  H Hocini; S Iscaki; C Benlahrache; L Vitalis; X Chevalier; B Larget-Piet; J P Bouvet
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

2.  Serum secretory immunoglobulins in ankylosing spondylitis.

Authors:  D Wendling; J M Didier; E Seilles
Journal:  Clin Rheumatol       Date:  1996-11       Impact factor: 2.980

3.  Immunoglobulin A in the skin of patients with ankylosing spondylitis.

Authors:  A Collado; R Sanmarti; I Bielsa; T Castel; E Kanterewicz; J D Cañete; M A Brancós; J Rotes-Querol
Journal:  Ann Rheum Dis       Date:  1988-12       Impact factor: 19.103

4.  Serum IgA, acute phase proteins, and glycosylation of alpha 1-acid glycoprotein in ankylosing spondylitis.

Authors:  A Mackiewicz; M A Khan; T L Reynolds; S van der Linden; I Kushner
Journal:  Ann Rheum Dis       Date:  1989-02       Impact factor: 19.103

5.  Differences in HLA-B27 positive and negative patients with ankylosing spondylitis: study of clinical disease activity and concentrations of serum IgA, C reactive protein, and haptoglobin.

Authors:  T L Reynolds; M A Khan; S van der Linden; R P Cleveland
Journal:  Ann Rheum Dis       Date:  1991-03       Impact factor: 19.103

6.  Higher Levels of Secretory IgA Are Associated with Low Disease Activity Index in Patients with Reactive Arthritis and Undifferentiated Spondyloarthritis.

Authors:  Fabián Salas-Cuestas; Wilson Bautista-Molano; Juan M Bello-Gualtero; Ivonne Arias; Diana Marcela Castillo; Lorena Chila-Moreno; Rafael Valle-Oñate; Daniel Herrera; Consuelo Romero-Sánchez
Journal:  Front Immunol       Date:  2017-04-27       Impact factor: 7.561
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.